ASCVD Risk estimator - Evidencio
ASCVD Risk estimator
The current tool is used to estimate the 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk. 

The ASCVD Risk Estimator is intended for patients without a prior atherosclerotic cardiovascular event or disease, between 40 and 79 years of age.

Contra-indications
The ASCVD Risk Estimator is not intended for patients who have already had an atherosclerotic cardiovascular event or disease. Further contra-indications may be found during the clinical evaluation.
 
Autores da investigação: David C. Goff Jr., Donald M. Lloyd-Jones, Glen Bennett, Sean Coady, Ralph B. D'Agostino, Raymond Gibbons, Philip Greenland, Daniel T. Lackland, Daniel Levy, Christopher J. O'Donnell, Jennifer G. Robinson, J. Sanford Schwartz, Susan T. Shero, Sidney C. Smith Jr., Paul Sorlie, Neil J. Stone, Peter W.F. Wilson
Versão: 1.22
  • Público
  • Cardiologia
  • {{ modelType }}
V-1.22-2903.24.05.31
(01)08719327522783(8012)v1.22(4326)240531(240)2903
Descarregar o Manual do utilizador e consultar o Utilização prevista.
Unidades

{{section.title}}

Calcular o resultado

Definir mais parâmetros para efetuar o cálculo

10-year ASCVD Risk is: %

{{ resultSubheader }}
{{ chart.title }}
Intervalo de resultados {{ additionalResult.min }} para {{ additionalResult.max }}

Informação condicional

The result of the ASCVD Risk Estimator can be used to inform a dialogue between a physician and their patient about their risk of cardiovascular disease, and guide discussions surrounding risk-reducing interventions, such as life-style intervention or preventative medication.

The ASCVD Risk Estimator was originally derived in a US cohort of patients, and may overestimate or underestimate risks in other populations. However, its discriminative ability remains good (AUROC: 0.75 (95% CI: 0.74, 0.77))

When deciding upon the use of preventative medications such as statins, it is recommended to use not just the 10-year ASCVD Risk, but also look at the individual risk factors for a patient. Precise risk categories depend and vary based upon the target population and the local guidance organisation, but risks above 10% are generally considered high, and risks above 20% very high.

{{ file.classification }}
PRO
Nota
As notas só são visíveis no descarregamento do resultado e não serão guardadas pelo Evidencio

Os cálculos, por si só, nunca devem ditar os cuidados a prestar aos doentes e não substituem o julgamento profissional. Ver o nosso disclaimer.

Algoritmos subjacentes Parte de
logo

Inicie sessão para ativar as funcionalidades de impressão do Evidencio

Para poder utilizar as funcionalidades de impressão do Evidencio, é necessário ter sessão iniciada.
Se não tem uma conta na Comunidade Evidencio, pode criar a sua conta pessoal gratuita em:

https://www.evidencio.com/registration

Resultados da impressão - Exemplos {{ new Date().toLocaleString() }}

Benefícios da conta comunitária Evidencio

With an Evidencio Community account you can:

  • Create and publish your own prediction algorithms.
  • Share your prediction algorithms with your colleagues, research group, organization or the world.
  • Review and provide feedback on algorithms that have been shared with you.
  • Validate your algorithms and validate algorithms from other users.
  • Find algorithms based on Title, Keyword, Author, Institute, or MeSH classification.
  • Use and save prediction algorithms and their data.
  • Use patient specific protocols and guidelines based on sequential algorithms and decision trees.
  • Stay up-to-date with new algorithms in your field as they are published.
  • Create your own lists of favorite algorithms and topics.

A personal Evidencio account is free, with no strings attached!
Join us and help create clarity, transparency, and efficiency in the creation, validation, and use of medical prediction algorithms.

Declaração de exoneração de responsabilidade: Os cálculos, por si só, nunca devem ditar os cuidados a prestar aos doentes e não substituem a apreciação profissional.
Terms & Conditions | Privacy Policy | Disclaimer | Contact | Refuse cookies |
Evidencio v3.35 © 2015 - 2025 Evidencio. All Rights Reserved